|
JAMA |
Aspirin for Secondary Prevention of Cardiovascular Disease in 51 Low-, Middle-, and High-Income Countries |
1 |
Yes |
8/22/2026 |
|
AMA Journal of Ethics |
Aspiring to Disability Consciousness in Health Professions Training |
1 |
Yes |
12/19/2026 |
|
JAMA Ophthalmology |
Assessing Eye Health and Eye Care Needs Among North American Native Individuals |
1 |
Yes |
2/17/2025 |
|
JAMA Internal Medicine |
Assessing How Consumers Interpret and Act on Results From At-Home COVID-19 Self-test Kits - A Randomized Clinical Trial |
1 |
Yes |
2/2/2025 |
|
JAMA Network Open |
Assessing Psychosocial Risk and Resilience to Support Readiness for Gene Therapy in Sickle Cell Disease - A Consensus Statement |
1 |
Yes |
8/21/2027 |
|
American Association for Physician Leadership |
Assessing the Health of Your Organization |
3.0 |
Yes |
3/26/2025 |
|
JAMA |
Assessing Unexpected Circumstances That Lead to Modifications in Clinical Trial Design, Conduct, or Analysis - Application of the CONSERVE Reporting Guideline |
1 |
Yes |
3/1/2025 |
|
JAMA Network Open |
Assessment of 4 Doses of SARS-CoV-2 Messenger RNABased Vaccine in Recipients of a Solid Organ Transplant |
1 |
Yes |
11/24/2024 |
|
JAMA Network Open |
Assessment of a Crisis Standards of Care Scoring System for Resource Prioritization and Estimated Excess Mortality by Race, Ethnicity, and Socially Vulnerable Area During a Regional Surge in COVID-19 |
1 |
Yes |
3/18/2025 |
|
JAMA Pediatrics |
Assessment of Changes in Child and Adolescent Screen Time During the COVID-19 Pandemic: A Systematic Review and Meta-analysis |
1 |
Yes |
11/14/2025 |
|
JAMA Network Open |
Assessment of Clinical Effectiveness of BNT162b2 COVID-19 Vaccine in US Adolescents |
1 |
Yes |
3/7/2025 |
|
JAMA Pediatrics |
Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries |
1 |
Yes |
1/21/2025 |
|
JAMA Network Open |
Assessment of Digital and Community-Based Outreach Interventions to Encourage COVID-19 Vaccination Uptake in an Underserved Community |
1 |
Yes |
6/29/2025 |
|
JAMA Neurology |
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura - A Secondary Analysis of Randomized Clinical Trials |
1 |
Yes |
2/14/2025 |
|
JAMA Network Open |
Assessment of Ethnic Inequities and Subpopulation Estimates in COVID-19 Vaccination in New Zealand |
1 |
Yes |
6/30/2025 |
|
JAMA Network Open |
Assessment of Mental Health of High School Students 1 Semester After COVID-19 Associated Remote Schooling Measures Were Lifted in Austria in 2021 |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment |
1 |
Yes |
11/24/2024 |
|
JAMA Oncology |
Assessment of Response to a Third Dose of the SARS-CoV-2 BNT162b2 mRNA Vaccine in Patients With Solid Tumors Undergoing Active Treatment |
1 |
Yes |
11/24/2024 |
|
JAMA Otolaryngology – Head & Neck Surgery |
Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination |
1 |
Yes |
3/7/2025 |
|
JAMA Internal Medicine |
Assessment of US Food and Drug Administration Approved Digital Medical Devices for Just-in-Time Interventions - A Systematic Review |
1 |
Yes |
7/17/2025 |